English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/90309
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Evolution of serum biochemical indicators in anorexia nervosa patients: a 1-year follow-up study

AuthorsNova, Esther ; López-Vidriero, Irene; Varela, P.; Casas, J.; Marcos, Ascensión
KeywordsRefeeding
Red blood cells
Follow-up
Restricting-type anorexia nervosa
Serum biochemical markers
Serum enzymatic activities.
Study
Issue Date2008
PublisherBlackwell Publishing
CitationJournal of Human Nutrition and Dietetics 21: 23- 30 (2008)
AbstractAbstract BACKGROUND: Long-term studies on the evolution of serum biochemical indicators in anorexia nervosa (AN) patients during treatment are lacking in the literature. Thus, a 1-year follow-up of serum biochemical parameters in a homogeneous group of AN patients was performed. METHODS: Fourteen restricting-type AN patients were studied on admission to hospital, after 1 month of inpatient treatment and after 6 and 12 months after admission. RESULTS: Red blood cell count (RBC) and haemoglobin, serum glucose, total protein and the enzyme activities aspartate aminotransferase (AST), alkaline phosphatase (AlP), lactate dehydrogenase (LDH) and creatine kinase (CK) were significantly lower in patients on admission than in the control group. Total protein, high-density lipoprotein cholesterol (HDL-c), AST, AlP and CK showed significant changes among time points (anova, P < 0.05). Significant correlations were found between the change in RBC, haemoglobin, haematocrit, and the change in weight and body mass index (r = 0.74-0.86; P < 0.01). High cholesterol and amylase activity were found at all time points. While AST, LDH and CK reached control values within 6 months of treatment, AlP was always lower. CONCLUSION: Serum AlP, hypercholesterolaemia and RBC seem to need longer periods of treatment with further weight gain to fully normalize. Therefore, these parameters should be monitored in AN patients long-term follow-up.
URIhttp://hdl.handle.net/10261/90309
DOI10.1111/j.1365-277X.2007.00833.x.
Identifiersdoi: 10.1111/j.1365-277X.2007.00833.x.
issn: 1365-277X
Appears in Collections:(IF) Artículos
Files in This Item:
File Description SizeFormat 
450392.pdf81,99 kBUnknownView/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.